Glen Oaks, NYNCT04763655Now EnrollingIRB Ready

Electroconvulsive Therapy Treated Patients Clinical Trial in Glen Oaks, NY

Access cutting-edge electroconvulsive therapy treated patients treatment through this clinical trial at a research site in Glen Oaks. Study-provided care at no cost to qualified participants.

Sponsored by Northwell Health

Quick Self-Assessment

See if you qualify for this Glen Oaks location

Preparing your pre-screening questions…

Expert Care in Glen Oaks

Access electroconvulsive therapy treated patients specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related electroconvulsive therapy treated patients treatment provided free

Apply for This Glen Oaks Location

Check if you qualify for this electroconvulsive therapy treated patients clinical trial in Glen Oaks, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Glen Oaks

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Glen Oaks site if eligible
  4. 4Begin participation

About This Electroconvulsive Therapy Treated Patients Study in Glen Oaks

In the proposed study, the investigators will utilize resting-state functional MRI (fMRI) and structural MRI-based electrical field modeling to study the effect of electroconvulsive therapy on human neural circuitry. Our study will recruit patients who are beginning treatment with bilateral electroconvulsive therapy (N=75). Our design will be longitudinal where patients will be followed up until their 8th week electroconvulsive therapy clinically. The primary measure of interest will be the slope of clinical change estimated with mixed effect modeling (see Approach). Secondary measures will be the cognitive performance change between baseline and the 8th week electroconvulsive therapy time point.

Sponsor: Northwell Health

Who Can Participate

Inclusion Criteria

current positive symptoms rated ≥4 (moderate) on one or more of these BPRS 53 items: hallucinatory behavior, unusual thought content, suspiciousness, conceptual disorganization;
has failed at least one trial of treatment with antipsychotic drug, lasting 6 weeks in duration,
competent and willing to sign informed consent;
for women, negative pregnancy test and agreement to use a medically accepted birth control method; and
Diagnostic and Statistical Manual (DSM)-IV diagnosis of schizophrenia, schizoaffective or schizophreniform disorder.

Exclusion Criteria

serious neurological or endocrine disorder;
any medical condition which requires treatment with a medication with psychotropic effects;
significant risk of suicidal or homicidal behavior;
cognitive (MMSE ≤ 23) or language limitations that would preclude subjects providing informed consent;
contraindications to treatment with electroconvulsive therapy;
contraindications to magnetic resonance imaging (e.g. pacemaker)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Glen Oaks?

Yes, this clinical trial (NCT04763655) has an active research site in Glen Oaks, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Electroconvulsive Therapy Treated Patients Treatment Options in Glen Oaks, NY

If you're searching for electroconvulsive therapy treated patients treatment options in Glen Oaks, NY, this clinical trial (NCT04763655) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Glen Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced electroconvulsive therapy treated patients specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all electroconvulsive therapy treated patients clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Glen Oaks, NY

See all rheumatoid arthritis clinical trials recruiting in Glen Oaks — not just this study.

Browse Rheumatoid Arthritis Trials in Glen Oaks

Ready to Join in Glen Oaks?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Glen Oaks, NY